Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Revvity Inc. has received an average rating of "Moderate Buy" from fifteen analysts, with one analyst recommending a sell, five a hold, and nine a buy.
• The current 1-year price target set by brokerages for Revvity is $116.62, despite recent reductions in target prices from various firms.
• Revvity announced a quarterly dividend of $0.07 per share, representing an annual yield of 0.3%, to be paid on November 7th.

Revvity Inc. (NYSE:RVTY - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fifteen analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $116.6154.

Several equities analysts have weighed in on RVTY shares. Guggenheim started coverage on Revvity in a research note on Wednesday. They issued a "neutral" rating on the stock. Bank of America cut their target price on Revvity from $110.00 to $99.00 and set a "buy" rating on the stock in a research note on Monday, September 22nd. Evercore ISI cut their target price on Revvity from $108.00 to $106.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 7th. Stifel Nicolaus cut their target price on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research note on Tuesday, July 29th. Finally, Wall Street Zen lowered Revvity from a "buy" rating to a "hold" rating in a research note on Sunday, August 3rd.

Revvity Trading Up 2.0%

Shares of RVTY opened at $94.00 on Friday. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. Revvity has a 12-month low of $81.36 and a 12-month high of $129.50. The firm has a market capitalization of $10.91 billion, a PE ratio of 39.83, a price-to-earnings-growth ratio of 3.07 and a beta of 0.98. The stock's fifty day simple moving average is $88.46 and its 200-day simple moving average is $92.53.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The business had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same quarter in the prior year, the firm posted $1.22 earnings per share. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, research analysts predict that Revvity will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity's dividend payout ratio is presently 11.86%.

Hedge Funds Weigh In On Revvity

Several hedge funds have recently added to or reduced their stakes in RVTY. HB Wealth Management LLC raised its position in shares of Revvity by 4.8% during the first quarter. HB Wealth Management LLC now owns 2,494 shares of the company's stock worth $264,000 after purchasing an additional 114 shares during the period. Farther Finance Advisors LLC grew its holdings in shares of Revvity by 21.2% during the first quarter. Farther Finance Advisors LLC now owns 796 shares of the company's stock worth $83,000 after buying an additional 139 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of Revvity by 25.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company's stock worth $73,000 after buying an additional 140 shares in the last quarter. Banque Transatlantique SA grew its holdings in shares of Revvity by 19.4% during the first quarter. Banque Transatlantique SA now owns 925 shares of the company's stock worth $90,000 after buying an additional 150 shares in the last quarter. Finally, Signaturefd LLC grew its holdings in shares of Revvity by 9.7% during the first quarter. Signaturefd LLC now owns 1,830 shares of the company's stock worth $194,000 after buying an additional 162 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.